Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 5
2005 5
2006 13
2007 17
2008 20
2009 20
2010 21
2011 28
2012 42
2013 53
2014 50
2015 63
2016 51
2017 50
2018 74
2019 80
2020 116
2021 92
Text availability
Article attribute
Article type
Publication date

Search Results

719 results
Results by year
Filters applied: . Clear all
Page 1
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial.
Cao Y, Wei J, Zou L, Jiang T, Wang G, Chen L, Huang L, Meng F, Huang L, Wang N, Zhou X, Luo H, Mao Z, Chen X, Xie J, Liu J, Cheng H, Zhao J, Huang G, Wang W, Zhou J. Cao Y, et al. Among authors: huang l. J Allergy Clin Immunol. 2020 Jul;146(1):137-146.e3. doi: 10.1016/j.jaci.2020.05.019. Epub 2020 May 26. J Allergy Clin Immunol. 2020. PMID: 32470486 Free PMC article. Clinical Trial.
S100 proteins in atherosclerosis.
Xiao X, Yang C, Qu SL, Shao YD, Zhou CY, Chao R, Huang L, Zhang C. Xiao X, et al. Among authors: huang l. Clin Chim Acta. 2020 Mar;502:293-304. doi: 10.1016/j.cca.2019.11.019. Epub 2019 Nov 30. Clin Chim Acta. 2020. PMID: 31794767 Review.
Safety of ceftriaxone in paediatrics: a systematic review.
Zeng L, Wang C, Jiang M, Chen K, Zhong H, Chen Z, Huang L, Li H, Zhang L, Choonara I. Zeng L, et al. Among authors: huang l. Arch Dis Child. 2020 Oct;105(10):981-985. doi: 10.1136/archdischild-2019-317950. Epub 2020 Mar 6. Arch Dis Child. 2020. PMID: 32144089 Free PMC article.
Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients.
Chen L, Long X, Xu Q, Tan J, Wang G, Cao Y, Wei J, Luo H, Zhu H, Huang L, Meng F, Huang L, Wang N, Zhou X, Zhao L, Chen X, Mao Z, Chen C, Li Z, Sun Z, Zhao J, Wang D, Huang G, Wang W, Zhou J. Chen L, et al. Among authors: huang l. Cell Mol Immunol. 2020 Sep;17(9):992-994. doi: 10.1038/s41423-020-0492-x. Epub 2020 Jul 3. Cell Mol Immunol. 2020. PMID: 32620787 Free PMC article. No abstract available.
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.
Wang N, Hu X, Cao W, Li C, Xiao Y, Cao Y, Gu C, Zhang S, Chen L, Cheng J, Wang G, Zhou X, Zheng M, Mao X, Jiang L, Wang D, Wang Q, Lou Y, Cai H, Yan D, Zhang Y, Zhang T, Zhou J, Huang L. Wang N, et al. Among authors: huang l. Blood. 2020 Jan 2;135(1):17-27. doi: 10.1182/blood.2019000017. Blood. 2020. PMID: 31697824 Free article. Clinical Trial.
SUMOylation in atherosclerosis.
Liu YZ, Xiao X, Hu CT, Dai Y, Qu SL, Huang L, Zhang C. Liu YZ, et al. Among authors: huang l. Clin Chim Acta. 2020 Sep;508:228-233. doi: 10.1016/j.cca.2020.05.033. Epub 2020 May 18. Clin Chim Acta. 2020. PMID: 32439557 Review.
Single-atom nanozymes.
Huang L, Chen J, Gan L, Wang J, Dong S. Huang L, et al. Sci Adv. 2019 May 3;5(5):eaav5490. doi: 10.1126/sciadv.aav5490. eCollection 2019 May. Sci Adv. 2019. PMID: 31058221 Free PMC article.
Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.
Huang L, Liu D, Wang N, Ling S, Tang Y, Wu J, Hao L, Luo H, Hu X, Sheng L, Zhu L, Wang D, Luo Y, Shang Z, Xiao M, Mao X, Zhou K, Cao L, Dong L, Zheng X, Sui P, He J, Mo S, Yan J, Ao Q, Qiu L, Zhou H, Liu Q, Zhang H, Li J, Jin J, Fu L, Zhao W, Chen J, Du X, Qing G, Liu H, Liu X, Huang G, Ma D, Zhou J, Wang QF. Huang L, et al. Cell Res. 2018 Feb;28(2):172-186. doi: 10.1038/cr.2017.146. Epub 2017 Nov 17. Cell Res. 2018. PMID: 29148541 Free PMC article.
719 results